ATARA BIOTHERAPEUTICS
Atara Biotherapeutics, Inc. (@Atarabio) is an off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral diseases. Atara’s technology platform leverages research collaborations with leading academic institutions with the Company’s scientific, clinical, regulatory, and manufacturing expertise. Atara’s pipeline includes tab-cel® (tabelecleucel), which is in Phase 3 development for patients with Epstein-Barr virus-associ... ated post-transplant lymphoproliferative disorder (EBV+ PTLD) as well as in earlier stage development for other EBV-associated hematologic malignancies and solid tumors, including nasopharyngeal carcinoma (NPC); T-cell immunotherapies targeting EBV antigens believed to be important for the potential treatment of multiple sclerosis; and next-generation chimeric antigen receptor T-cell (CAR T) immunotherapies. The company was founded in 2012 and is co-located in South San Francisco and Southern California. Our Southern California hub is anchored by the state-of-the-art Atara T-cell Operations and Manufacturing (ATOM) facility in Thousand Oaks, California. For additional information about the company, please visit atarabio.com.
ATARA BIOTHERAPEUTICS
Industry:
Biotechnology Health Care Oncology Therapeutics
Founded:
2012-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.atarabio.com
Total Employee:
251+
Status:
Active
Contact:
+1 650 278 8930
Email Addresses:
[email protected]
Total Funding:
499.82 M USD
Technology used in webpage:
Domain Not Resolving LetsEncrypt HSTS JsDelivr U.S. Server Location Microsoft CloudFront PostalAddress Schema Microsoft Azure Amazon California Region
Similar Organizations
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Cero Therapeutics
CERo Therapeutics, Inc. is a new cellular immunotherapy company.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Peroxitech Therapeutics
Peroxitech Therapeutics operates as a biopharmaceutical company.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Domain Associates
Domain Associates investment in Series B - Atara Biotherapeutics
DAG Ventures
DAG Ventures investment in Series B - Atara Biotherapeutics
Celgene
Celgene investment in Series B - Atara Biotherapeutics
Alexandria
Alexandria investment in Series B - Atara Biotherapeutics
Kleiner Perkins
Kleiner Perkins investment in Series B - Atara Biotherapeutics
EcoR1 Capital
EcoR1 Capital investment in Series B - Atara Biotherapeutics
Amgen Ventures
Amgen Ventures investment in Series B - Atara Biotherapeutics
Domain Associates
Domain Associates investment in Series B - Atara Biotherapeutics
Kleiner Perkins
Kleiner Perkins investment in Series B - Atara Biotherapeutics
Alexandria
Alexandria investment in Series B - Atara Biotherapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-05 | Atara Biotherapeutics Names Biopharmaceutical Executive Charlene Banard as Chief Technical Officer |
Official Site Inspections
http://www.atarabio.com Semrush global rank: 3.49 M Semrush visits lastest month: 3.75 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Atara Biotherapeutics"
T-Cell Immunotherapy Technology Platform - Atara Biotherapeutics
Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral diseases.See details»
Atara Bio Company Profile | Management and Employees List
SQL International Organization for Standardization . Lua PUC-Rio . HTML Web Hypertext Application Technology Working Group . CSS World Wide Web Consortium . Enterprise …See details»
Atara Biotherapeutics - Crunchbase Company Profile & Funding
Atara Biotherapeutics, Inc. (@Atarabio) is an off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral …See details»
Atara Biotherapeutics (ATRA)
Nov 12, 2024 Atara is harnessing the natural power of the immune system to develop off-the-shelf cell therapies for difficult-to-treat cancers and autoimmune conditions that can be rapidly …See details»
Atara Biotherapeutics - LinkedIn
Atara Biotherapeutics | 37,236 followers on LinkedIn. Pioneering off-the-shelf, allogeneic T-cell immunotherapies | Atara Biotherapeutics Inc., is a leading allogeneic T-cell immunotherapy …See details»
Responsibility - Atara Biotherapeutics
However, as a clinical stage biotechnology company pushing the boundaries of science, we recognize there is always more that can be done. We actively seek ways to ensure diversity, …See details»
Atara Biotherapeutics Enters Strategic Manufacturing Partnership …
Jan 26, 2022 Atara Biotherapeutics, Inc. (@Atarabio) is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for …See details»
News & Events - Atara Biotherapeutics
May 20, 2024 Atara is headquartered in Southern California. For more information, visit atarabio.com and follow @Atarabio on X and LinkedIn. Forward-Looking Statements. This …See details»
Atara Biotherapeutics - Craft
Sep 9, 2024 Atara Biotherapeutics is a company that provides allogeneic T-cell immunotherapy solutions. It offers investigational therapies that target various diseases caused by Epstein …See details»
Career Areas - Atara Biotherapeutics
Atara is committed to partnering with graduate and undergraduate programs to find the most promising talent. We begin recruiting in the fall for internship programs that take place the …See details»
Atara Biotherapeutics Announces Second Quarter 2022 Financial …
Aug 8, 2022 Atara announced plans to focus its activities as a leaner organization centered on R&D to further advance the Company’s innovative pipeline, while reducing cash burn ... News …See details»
Atara Biotherapeutics - Overview, News & Similar companies
May 15, 2024 Atara Biotherapeutics contact info: Phone number: (805) 623-4211 Website: www.atarabio.com What does Atara Biotherapeutics do? Founded in 2012, Atara Bio is a …See details»
Developing Novel T-Cell Immunotherapy Treatments - Atara …
Our clinical studies evaluate the potential of our investigational treatments in a well-defined patient population with eligibility criteria that allow for appropriate assessment of safety and clinical …See details»
Atara Biotherapeutics: Culture - LinkedIn
Atara Biotherapeutics | 37,193 followers on LinkedIn. Pioneering off-the-shelf, allogeneic T-cell immunotherapies | Atara Biotherapeutics Inc., is a leading allogeneic T-cell immunotherapy …See details»
Atara Biotherapeutics to Present Recent Progress and Key …
Jan 8, 2024 A live audio webcast of the presentation will be available by visiting the Investors & Media – News & Events section of atarabio.com on Thursday, January 11, at 9:45 a.m. PST / …See details»
Collaborations - Atara Biotherapeutics
Memorial Sloan Kettering Cancer Center Tabelecleucel (tab-cel ®)*. In 2015, Atara entered into a worldwide license agreement with Memorial Sloan Kettering Cancer Center (MSK) for the …See details»
Working at Atara Biotherapeutics - Zippia
Mar 14, 2024 Organization Type. Public. Social Media. Atara Biotherapeutics, Inc. (@Atarabio) is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel …See details»
Atara Biotherapeutics and Pierre Fabre Laboratories Announce ...
Jan 31, 2024 [email protected]. Jason Awe, Ph.D. Senior Director, Corporate Communications & Investor Relations (805) 217-2287 [email protected]. Pierre Fabre …See details»
Atara Biotherapeutics Announces Fourth Quarter and Full Year …
Feb 8, 2023 For additional information about the company, please visit atarabio.com and follow us on Twitter and LinkedIn. Forward-Looking Statements This press release contains or may …See details»